James O’Donnell
@jsodonnell.bsky.social
Reposted by James O’Donnell
Low VWF–QL is a distinct clinicopathological entity compared with type 2 VWD. buff.ly/X35uyr5 #hemesky
July 18, 2025 at 5:02 PM
Low VWF–QL is a distinct clinicopathological entity compared with type 2 VWD. buff.ly/X35uyr5 #hemesky
Reposted by James O’Donnell
According to new RCSI research, immune cells that 'remember' past inflammation could increase the risk of blood clots in the long term.
The 'shortened fuse' in these cells may contribute to a higher blood clot risk in inflammatory conditions.
Read more 🔗 www.rcsi.com/dublin/news-...
#RCSIdiscover
The 'shortened fuse' in these cells may contribute to a higher blood clot risk in inflammatory conditions.
Read more 🔗 www.rcsi.com/dublin/news-...
#RCSIdiscover
March 10, 2025 at 9:22 AM
According to new RCSI research, immune cells that 'remember' past inflammation could increase the risk of blood clots in the long term.
The 'shortened fuse' in these cells may contribute to a higher blood clot risk in inflammatory conditions.
Read more 🔗 www.rcsi.com/dublin/news-...
#RCSIdiscover
The 'shortened fuse' in these cells may contribute to a higher blood clot risk in inflammatory conditions.
Read more 🔗 www.rcsi.com/dublin/news-...
#RCSIdiscover
Reposted by James O’Donnell
New RCSI research has uncovered how T cells may contribute to blood clot risk in inflammatory bowel disease.
The findings, published in @NatureComms also suggest a potential treatment approach to manage this risk.
Read more 🔗 www.rcsi.com/dublin/news-...
#RCSIdiscover @rcsi-research.bsky.social
The findings, published in @NatureComms also suggest a potential treatment approach to manage this risk.
Read more 🔗 www.rcsi.com/dublin/news-...
#RCSIdiscover @rcsi-research.bsky.social
New RCSI research identifies key role of T cells in blood clot risk for inflammatory bowel disease patients
Researchers from RCSI University of Medicine and Health Sciences have uncovered a novel mechanism linking inflammatory bowel disease (IBD) with an increased risk of a serious blood clotting disorder, ...
www.rcsi.com
February 21, 2025 at 9:47 AM
New RCSI research has uncovered how T cells may contribute to blood clot risk in inflammatory bowel disease.
The findings, published in @NatureComms also suggest a potential treatment approach to manage this risk.
Read more 🔗 www.rcsi.com/dublin/news-...
#RCSIdiscover @rcsi-research.bsky.social
The findings, published in @NatureComms also suggest a potential treatment approach to manage this risk.
Read more 🔗 www.rcsi.com/dublin/news-...
#RCSIdiscover @rcsi-research.bsky.social
Reposted by James O’Donnell
Really good article in @jthjournal.bsky.social about how to deal with persons who have von Willebrand factor levels of 30-50%. The key is how "significant bleeding phenotype" is defined. tinyurl.com/y55mwkj3 #willebrand #VWD
November 29, 2024 at 7:11 PM
Really good article in @jthjournal.bsky.social about how to deal with persons who have von Willebrand factor levels of 30-50%. The key is how "significant bleeding phenotype" is defined. tinyurl.com/y55mwkj3 #willebrand #VWD